XML 82 R71.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders’ Deficit - Schedule of common stock issuable upon exercise of warrants outstanding (Details) | 9 Months Ended
--- | ---
Sep. 30, 2025 $ / shares shares
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 26,090,232
Number of Warrants Exercised (in shares) | 4,312,720
Number of Warrants Cancelled (in shares) | 472,500
Number of Warrants Exercisable (in shares) | 21,305,012
Adjusted Number of Warrants Exercisable (in shares) | 50,150,651
Public Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 7,188
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 7,188
Exercise price (in dollars per share) | $ / shares | $ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 4,600
Adjusted Number of Warrants Exercisable (in shares) | 7,188
Private Warrants - February 2020 |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 341
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 341
Exercise price (in dollars per share) | $ / shares | $ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 4,600
Adjusted Number of Warrants Exercisable (in shares) | 341
PIPE Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,384
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 3,384
Exercise price (in dollars per share) | $ / shares | $ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 4,600
Adjusted Number of Warrants Exercisable (in shares) | 3,384
2022 July Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 10,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 10,000
Exercise price (in dollars per share) | $ / shares | $ 1,500
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1,500
Adjusted Number of Warrants Exercisable (in shares) | 10,000
Underwriter Warrants - February 2024 offering |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 48,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 22,500
Number of Warrants Exercisable (in shares) | 25,500
Exercise price (in dollars per share) | $ / shares | $ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 20.00
Adjusted Number of Warrants Exercisable (in shares) | 25,500
2024 February Institutional/Accredited Investor Warrants - series A |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 480,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 480,000
Exercise price (in dollars per share) | $ / shares | $ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 20.00
Adjusted Number of Warrants Exercisable (in shares) | 480,000
2024 February Institutional/Accredited Investor Warrants - series C |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 480,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 450,000
Number of Warrants Exercisable (in shares) | 30,000
Exercise price (in dollars per share) | $ / shares | $ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 20.00
Adjusted Number of Warrants Exercisable (in shares) | 30,000
2024 October Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 2,076,036
Number of Warrants Exercised (in shares) | 1,700,351
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 375,685
Exercise price (in dollars per share) | $ / shares | $ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.1711
Adjusted Number of Warrants Exercisable (in shares) | 1,623,501
2024 December Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 277,780
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 277,780
Exercise price (in dollars per share) | $ / shares | $ 1.00
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.00
Adjusted Number of Warrants Exercisable (in shares) | 277,780
2025 March Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 1,777,750
Number of Warrants Exercised (in shares) | 285,028
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 1,492,722
Exercise price (in dollars per share) | $ / shares | $ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.1711
Adjusted Number of Warrants Exercisable (in shares) | 6,483,939
2025 April Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 1,953,537
Number of Warrants Exercised (in shares) | 769,546
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 1,183,991
Exercise price (in dollars per share) | $ / shares | $ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.1711
Adjusted Number of Warrants Exercisable (in shares) | 4,980,253
2025 May Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 5,341,879
Number of Warrants Exercised (in shares) | 50,000
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 5,291,879
Exercise price (in dollars per share) | $ / shares | $ 0.78
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.1711
Adjusted Number of Warrants Exercisable (in shares) | 24,102,223
2025 July Institutional/Accredited Investor Pre-funded Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 1,984,940
Number of Warrants Exercised (in shares) | 1,507,795
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 477,145
Exercise price (in dollars per share) | $ / shares | $ 0.0001
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.0001
Adjusted Number of Warrants Exercisable (in shares) | 477,145
2025 September Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 649,393
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 649,393
Exercise price (in dollars per share) | $ / shares | $ 0.1711
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 0.1711
Adjusted Number of Warrants Exercisable (in shares) | 649,393
Warrants - May 7, 2025 - 1st Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,000,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 3,000,000
Exercise price (in dollars per share) | $ / shares | $ 1.05
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.05
Adjusted Number of Warrants Exercisable (in shares) | 3,000,000
Warrants - May 7, 2025 - 2nd Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,000,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 3,000,000
Exercise price (in dollars per share) | $ / shares | $ 1.25
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.25
Adjusted Number of Warrants Exercisable (in shares) | 3,000,000
Warrants - May 7, 2025 - 3rd Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,000,000
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 3,000,000
Exercise price (in dollars per share) | $ / shares | $ 1.50
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.50
Adjusted Number of Warrants Exercisable (in shares) | 3,000,000
Warrants - May 18, 2025 - 1st Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 666,668
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 666,668
Exercise price (in dollars per share) | $ / shares | $ 1.00
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.00
Adjusted Number of Warrants Exercisable (in shares) | 666,668
Warrants - May 18, 2025 - 2nd Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 666,668
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 666,668
Exercise price (in dollars per share) | $ / shares | $ 1.25
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.25
Adjusted Number of Warrants Exercisable (in shares) | 666,668
Warrants - May 18, 2025 - 3rd Tranche |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 666,668
Number of Warrants Exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 666,668
Exercise price (in dollars per share) | $ / shares | $ 1.50
Adjusted Exercise Price (In dollars per shares) | $ / shares | $ 1.50
Adjusted Number of Warrants Exercisable (in shares) | 666,668

X
- Definition Class of Warrant Or Right, Adjusted Exercise Price Of Warrants Or Rights + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights
Namespace Prefix: | nvve_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Class of Warrant Or Right , Adjusted Number Of Warrants Exercisable + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightAdjustedNumberOfWarrantsExercisable
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Class of Warrant or Right, Exercised + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightExercised
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class of Warrant or Right, Number Of Warrants Exercisable + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightNumberOfWarrantsExercisable
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Warrants Cancelled + References No definition available. + Details
Name: | nvve_NumberOfWarrantsCancelled
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvve_StockholdersEquityDetailsScheduleofcommonstockissuableuponexerciseofwarrantsoutstandingLineItems
Namespace Prefix: | nvve_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of increase (decrease) in shares of stock classified as other. + References No definition available. + Details
Name: | us-gaap_StockholdersEquityOtherShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PrivateWarrantsFebruary2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PIPEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_July2022InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_UnderwriterWarrantsFebruary2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_October2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_December2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_March2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_April2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_July2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_September2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants1stTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants2ndTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants3rdTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants4thTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants5thTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants6thTrancheMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |